Non-Cardiovascular Comorbidities as Evaluated by Elixhauser Comorbidity Score in Individuals Undergoing TAVR
Vinayak Nagaraja(Royal Stoke University Hospital), Mamas A. Mamas(University Hospitals of North Midlands NHS Trust), Mauricio G. Cohen(Santa Ana College), William Suh, Rodrigo Bagur, Jessica Potts(Keele University), Mirvat Alasnag(King Fahd Armed Forces Hospital), Mark Gunning(Royal Stoke University Hospital), Philippe Généreux(Morristown Medical Center)
Cited by 6
Related Papers
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
|Journal of the American College of Cardiology|2021|1.5k
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research
|Journal of the American College of Cardiology|2021|1.2k
Preeclampsia and Future Cardiovascular Health
|Circulation Cardiovascular Quality and Outcomes|2017|1.1k